Pancreatic Neuroendocrine Neoplasm clinical trials at UCSD
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)
San Diego, California and other locations
Our lead scientists for Pancreatic Neuroendocrine Neoplasm research studies include Paul Fanta, MD.